<p>, /PRNewswire/ -- Biocoat 今天宣布成立 Surmodics Services &amp; Technologies，这是一个新命名的部门，将继续推进 Biocoat 在与 Surmodics 合并后剩余的业务部分，并在交易中剥离某些 Biocoat 资产。</p>
<p>Surmodics Services &amp; Technologies 代表了未被剥离的 Biocoat 传统业务运营。该部门现在将作为 Surmodics 组织的一部分以新名称运营。Surmodics Services &amp; Technologies 总部位于宾夕法尼亚州霍舍姆，将继续为全球医疗器械制造商提供一系列先进的亲水性和其他涂层技术以及专业服务。www.SurmodicsST.com</p>
<p>Surmodics Services &amp; Technologies 作为一个灵活且高度以客户为中心的组织，旨在与医疗器械制造商在开发过程的每个阶段紧密合作。该部门的项目开发和工程团队拥有数十年的专业知识，能够快速可靠地从早期概念推进到商业化。</p>
<p>霍舍姆设施为初创企业、合同制造商和主要原始设备制造商提供完全可扩展的解决方案。该部门具备从早期配方、可行性测试、优化到全涂层生产的端到端能力，旨在加速创新并支持设备的整个生命周期。</p>
<p>&#34;今天标志着我们组织和我们服务的客户的重要里程碑，&#34; Surmodics 首席执行官 Chip Hance 说。&#34;通过 Surmodics Services &amp; Technologies，我们继续建立一个专注、灵活且以创新为驱动的部门，基于数十年的科学卓越。在这个新身份下，我们将继续与设备制造商紧密合作，将下一代医疗技术带给全球患者。&#34;</p>
<p><strong>关于 Surmodics Services &amp; Technologies</strong></p>
<p>Surmodics Services &amp; Technologies 是 Surmodics 的一个部门，提供先进的亲水涂层解决方案、自定义聚合物配方和医疗器械行业的全方位涂层服务。总部位于宾夕法尼亚州霍舍姆，SST 支持客户从早期开发到全面生产，并与初创企业、合同开发制造组织（CDMO）和原始设备制造商（OEM）合作，加速创新并提升设备性能。</p>
<p><strong>关于 Surmodics, Inc.</strong></p>
<p>Surmodics 是为血管内医疗设备提供性能涂层技术以及为体外诊断免疫测定测试和微阵列提供化学和生物组件的领先供应商。Surmodics 还开发和商业化高度差异化的血管介入医疗设备，旨在满足未满足的临床需求，并按照最严格的要求进行工程设计。该关键增长战略利用了公司在专有表面改性和药物输送涂层技术方面的专业知识，以及其设备设计、开发和制造能力。公司的使命是改善疾病的检测和治疗。Surmodics 总部位于明尼苏达州伊登草原。有关更多信息，请访问 www.surmodics.com。</p>
<p>来源：Biocoat, Inc.</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjEwJk5ld3NJdGVtSWQ9UEg0MzcwMyZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMTAxMjA3UFJfTkVXU19VU1BSX19fX19QSDQzNzAz?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjEwJk5ld3NJdGVtSWQ9UEg0MzcwMyZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMTAxMjA3UFJfTkVXU19VU1BSX19fX19QSDQzNzAz"/></p>

SRDX

<p>Biocoat 宣布成立 Surmodics Services & Technologies，这是在与 Surmodics 合并并剥离某些资产后成立的新部门。该部门将在 Surmodics 旗下运营，专注于为医疗设备制造商提供亲水涂层技术和服务。其目标是加速创新，并在设备的整个生命周期内提供支持，采用以客户为中心的方法，并具备开发和工程方面的专业知识</p>

<p>, /PRNewswire/ -- Biocoat today announced the formation of Surmodics Services &amp; Technologies, a newly named division that will carry forward the portion of Biocoat's business remaining after merging with Surmodics and divesting certain Biocoat assets in connection with the transaction.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- Biocoat 今天宣布成立 Surmodics Services &amp; Technologies，这是一个新命名的部门，将继续推进 Biocoat 在与 Surmodics 合并后剩余的业务部分，并在交易中剥离某些 Biocoat 资产。</p>
</div><p>Surmodics Services &amp; Technologies represents the legacy Biocoat business operations that were not divested. This division will now operate as part of the Surmodics organization under its new name. Based in Horsham, Pennsylvania, Surmodics Services &amp; Technologies will continue delivering an array of advanced hydrophilic and other coating technologies as well as specialized services to medical device manufacturers worldwide. www.SurmodicsST.com</p>
<div class="lb-trans"><p>Surmodics Services &amp; Technologies 代表了未被剥离的 Biocoat 传统业务运营。该部门现在将作为 Surmodics 组织的一部分以新名称运营。Surmodics Services &amp; Technologies 总部位于宾夕法尼亚州霍舍姆，将继续为全球医疗器械制造商提供一系列先进的亲水性和其他涂层技术以及专业服务。www.SurmodicsST.com</p>
</div><p>Structured as a nimble and highly customer-centric organization, Surmodics Services &amp; Technologies is designed to work closely with medical device manufacturers at every stage of the development process. The division's Project Development and Engineering team brings decades of expertise, enabling fast and reliable progression from early concept through commercialization.</p>
<div class="lb-trans"><p>Surmodics Services &amp; Technologies 作为一个灵活且高度以客户为中心的组织，旨在与医疗器械制造商在开发过程的每个阶段紧密合作。该部门的项目开发和工程团队拥有数十年的专业知识，能够快速可靠地从早期概念推进到商业化。</p>
</div><p>The Horsham facility provides fully scalable solutions for start-ups, contract manufacturers, and major original equipment manufacturers. With end-to-end capabilities that include early-stage formulation, feasibility testing, optimization, and full coating production, the division is positioned to accelerate innovation and support devices across their full lifecycle.</p>
<div class="lb-trans"><p>霍舍姆设施为初创企业、合同制造商和主要原始设备制造商提供完全可扩展的解决方案。该部门具备从早期配方、可行性测试、优化到全涂层生产的端到端能力，旨在加速创新并支持设备的整个生命周期。</p>
</div><p>&#34;Today marks a significant milestone for our organization and for the customers we serve,&#34; said Chip Hance, CEO of Surmodics. &#34;With Surmodics Services &amp; Technologies, we continue with a focused, agile, and innovation-driven division built on decades of scientific excellence. Under this new identity, we will continue to partner closely with device manufacturers to bring next-generation medical technologies to patients around the world.&#34;</p>
<div class="lb-trans"><p>&#34;今天标志着我们组织和我们服务的客户的重要里程碑，&#34; Surmodics 首席执行官 Chip Hance 说。&#34;通过 Surmodics Services &amp; Technologies，我们继续建立一个专注、灵活且以创新为驱动的部门，基于数十年的科学卓越。在这个新身份下，我们将继续与设备制造商紧密合作，将下一代医疗技术带给全球患者。&#34;</p>
</div><p><strong>About Surmodics Services &amp; Technologies</strong></p>
<div class="lb-trans"><p><strong>关于 Surmodics Services &amp; Technologies</strong></p>
</div><p>Surmodics Services &amp; Technologies is a division of Surmodics that provides advanced hydrophilic coating solutions, custom polymer formulations, and full-service coating operations for the medical device industry. Headquartered in Horsham, Pennsylvania, SST supports customers from early-stage development through full production and partners with start-ups, CDMOs, and OEMs to accelerate innovation and enhance device performance.</p>
<div class="lb-trans"><p>Surmodics Services &amp; Technologies 是 Surmodics 的一个部门，提供先进的亲水涂层解决方案、自定义聚合物配方和医疗器械行业的全方位涂层服务。总部位于宾夕法尼亚州霍舍姆，SST 支持客户从早期开发到全面生产，并与初创企业、合同开发制造组织（CDMO）和原始设备制造商（OEM）合作，加速创新并提升设备性能。</p>
</div><p><strong>About Surmodics, Inc.</strong></p>
<div class="lb-trans"><p><strong>关于 Surmodics, Inc.</strong></p>
</div><p>Surmodics is a leading provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. Surmodics also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. This key growth strategy leverages the combination of the Company's expertise in proprietary surface modification and drug-delivery coating technologies, along with its device design, development, and manufacturing capabilities. The Company's mission is to improve the detection and treatment of disease. Surmodics is headquartered in Eden Prairie, Minnesota. For more information, visit www.surmodics.com.</p>
<div class="lb-trans"><p>Surmodics 是为血管内医疗设备提供性能涂层技术以及为体外诊断免疫测定测试和微阵列提供化学和生物组件的领先供应商。Surmodics 还开发和商业化高度差异化的血管介入医疗设备，旨在满足未满足的临床需求，并按照最严格的要求进行工程设计。该关键增长战略利用了公司在专有表面改性和药物输送涂层技术方面的专业知识，以及其设备设计、开发和制造能力。公司的使命是改善疾病的检测和治疗。Surmodics 总部位于明尼苏达州伊登草原。有关更多信息，请访问 www.surmodics.com。</p>
</div><p>SOURCE Biocoat, Inc.</p>
<div class="lb-trans"><p>来源：Biocoat, Inc.</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjEwJk5ld3NJdGVtSWQ9UEg0MzcwMyZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMTAxMjA3UFJfTkVXU19VU1BSX19fX19QSDQzNzAz" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=PH43703&amp;Transmission_Id=202512101207PR_NEWS_USPR_____PH43703&amp;DateId=20251210"/></p>

Biocoat 宣布在合并和剥离交易后成立 Surmodics 服务与技术部门